PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Sebastian Szubert

Poznan University of Medical Sciences

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies

Cancers

A narrative review synthesizing preclinical and clinical evidence across multiple therapeutic modalities for ovarian cancer, identifying mature strategies (PARP inhibitors, antiangiogenic agents) and early-stage approaches, intended to guide therapeutic selection and future research directions.

Expert GuidanceJoanna Pietrasik Mikołaj Kapała Justyna Mikuła‐Pietrasik

Reported

5-year survival, advanced-stage o…approximately 29%

Median relapse timing post-standa…within 2 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support